|
Ventana Medical Systems, Inc. is pleased to announce it has received FDA approval for the use of its PATHWAY® HER-2/neu (4B5) Rabbit Monoclonal Antibody as an aid in the assessment of breast cancer patients for whom Herceptin® treatment is considered. This antibody has also been approved for use on the Ventana Image Analysis System (VIAS™). Press Release.
|
 |
Welcome to Ventana
Ventana Medical is the world’s leading supplier of automated diagnostic systems to the anatomical pathology market. Our instrument and reagent systems are used in clinical histology, cytology, and drug discovery laboratories around the globe. Through automation and systems integration, Ventana is standardizing and optimizing the slide staining process, thereby helping pathologists recommend treatment solutions that deliver superior patient care.
Our customers consist of hospital-based histology labs, independent reference labs, medical research centers, and drug discovery laboratories of the largest pharmaceutical and biotechnology companies in the world.
|
